The OHSU researchers call their test “PAC-MANN,” which stands for “protease activity-based assay using a magnetic nanosensor.

As with MCN, patients with borderline tumors or carcinoma in situ are usually cured. With invasive carcinoma, the 5 and 10-year survival is 60% and 50% which is much better than typical pancreatic ...

KYOTO--Researchers here say they developed a highly accurate method to detect early signs of pancreatic cancer using artificial intelligence (AI). This form of cancer invariably proves fatal ...